Katz R L, Hirsch-Ginsberg C, Childs C, Dekmezian R, Fanning T, Ordóñez N, Cabanillis F, Sneige N
Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Am J Clin Pathol. 1991 Oct;96(4):479-90. doi: 10.1093/ajcp/96.4.479.
To assess the efficacy of performing genotyping in addition to immunophenotyping as an adjunct to cytologic diagnosis, 63 consecutive patients with fine-needle aspirates of lymphoproliferative lesions who had concurrent immunophenotyping and genotyping performed on fine-needle aspirate cell suspensions were studied. Thirty-nine of 63 specimens (62%) that appeared to contain non-Hodgkin's lymphoma and that proved to be of B-cell lineage by genotyping were accurately phenotyped and shown to be monotypic for immunoglobulin light chains by cell suspension immunocytochemistry. Genotyping facilitated lineage assignment and/or confirmed clonality in 17 of 63 specimens (27%) that were difficult to determine based on morphologic data. These include cases of atypical lymphoid proliferations with polyclonal or inconclusive markers (n = 6), peripheral T-cell lymphoma (n = 3), extracutaneous mycosis fungoides (n = 1), lymphoblastic lymphoma (n = 4), null cell lymphoma (n = 1), and specimens with equivocal or technically unsatisfactory markers (n = 2). Based on these results, it is proposed that genotyping for lineage assignment and/or clonality be performed to include cases of atypical lymphoid proliferations, T-cell malignant neoplasms, lymphoid malignant neoplasms with equivocal markers, and differentiation of lymphoid from nonlymphoid neoplasms. Genotyping by antigen-receptor gene rearrangement appears to be redundant in cases with mature B-cell phenotypes that demonstrate monoclonality by immunophenotyping.
为评估除免疫表型分析外进行基因分型作为细胞诊断辅助手段的疗效,我们研究了63例连续的经细针穿刺获取淋巴增殖性病变细胞悬液并同时进行免疫表型分析和基因分型的患者。63份标本中有39份(62%)看似含有非霍奇金淋巴瘤,经基因分型证实为B细胞谱系,通过细胞悬液免疫细胞化学准确地进行了表型分析,并显示免疫球蛋白轻链为单型。基因分型有助于在63份标本中的17份(27%)基于形态学数据难以确定谱系归属和/或克隆性的标本中进行谱系归属判定和/或确认克隆性。这些包括具有多克隆或不确定标记的非典型淋巴样增生病例(n = 6)、外周T细胞淋巴瘤(n = 3)、皮肤外蕈样霉菌病(n = 1)、淋巴母细胞淋巴瘤(n = 4)、裸细胞淋巴瘤(n = 1)以及标记不明确或技术上不满意的标本(n = 2)。基于这些结果,建议进行基因分型以确定谱系归属和/或克隆性,包括非典型淋巴样增生、T细胞恶性肿瘤、标记不明确的淋巴样恶性肿瘤以及区分淋巴样肿瘤与非淋巴样肿瘤的病例。在通过免疫表型分析显示为单克隆性的成熟B细胞表型病例中,通过抗原受体基因重排进行基因分型似乎是多余的。